Copaiba oil has been largely used due to its therapeutic properties. Nanocapsules were revealed to be a great nanosystem to carry natural oils due to their ability to improve the bioaccessibility and the bioavailability of lipophilic compounds. The aim of this study was to produce and characterize copaiba oil nanocapsules (CopNc) and to evaluate their hemocompatibility, cytotoxicity, and genotoxicity. Copaiba oil was chemically characterized by GC-MS and FTIR. CopNc was produced using the nanoprecipitation method. The physicochemical stability, toxicity, and biocompatibility of the systems, in vitro, were then evaluated. Β-bisabolene, cis-α-bergamotene, caryophyllene, and caryophyllene oxide were identified as the major copaiba oil components. CopNc showed a particle size of 215 ± 10 nm, a polydispersity index of 0.15 ± 0.01, and a zeta potential of −18 ± 1. These parameters remained unchanged over 30 days at 25 ± 2 °C. The encapsulation efficiency of CopNc was 54 ± 2%. CopNc neither induced hemolysis in erythrocytes, nor cytotoxic and genotoxic in lung cells at the range of concentrations from 50 to 200 μg·mL−1. In conclusion, CopNc showed suitable stability and physicochemical properties. Moreover, this formulation presented a remarkable safety profile on lung cells. These results may pave the way to further use CopNc for the development of phytotherapeutic medicine intended for pulmonary delivery of copaiba oil.
Sulfated polysaccharides (SP) from seaweeds have attracted increasing attention due to their biological properties. In this study, SP from the F0.5v sample of Caulerpa sertularioides were purified by ion-exchange chromatography, yielding two isolated samples (CS0.5 and CS0.8). Structural characterization by NMR spectroscopy revealed that both samples share the same backbone, corresponding to a 2-O-sulfated β-(1→6)-galactan. To the best of our knowledge, this is the first structural elucidation of SP from C. sertularioides exhibiting osteogenesis-related effects. Despite their structural similarity, HPSEC-MALLS analysis demonstrated clear differences in molecular weight (MW), with CS0.5 and CS0.8 presenting MW values of 1.42×10⁵ and 2.37×10⁵ g/mol, respectively. Their osteogenesis-related effects were evaluated in human mesenchymal stromal cells isolated from Wharton’s jelly (hMSC-WJ) cultured under basal and osteogenic conditions at concentrations of 7, 17, and 35 nM. Both samples increased alkaline phosphatase (ALP) activity and extracellular matrix (ECM) mineralization, indicating their role in osteogenic differentiation. Notably, CS0.8 exhibited stronger effects, even at 7 nM, likely due to its higher MW. These findings suggest polymer size impacts the biological activity of sulfated β-(1→6)-galactans, warranting further study for bone tissue engineering applications.